How to Control Myopia in Kids: Atropine and Ortho-K?

Myopia control in children matters more than ever because myopia starts in childhood, between ages 6 and 14, and global prevalence is projected to keep rising over the coming decades. 

Parents hear about atropine eye drops for myopia and orthokeratology for myopia, but it can be hard to understand what actually works, what the risks are, and when treatment should begin. 

This blog explains myopia progression in children, compares the two main options, and shows what else helps in real life.

What Is Myopia and Why Does It Progress in Children?

Myopia, or nearsightedness, happens when the eye grows too long from front to back or when its focusing system is too strong, so light focuses in front of the retina instead of on it. That is why distant objects look blurry while near work still feel clear.

In children, the bigger issue is not only having glasses power, but the eye continuing to grow longer over time. Younger age at onset is important because myopia tends to progress faster in younger children, and common risk factors include family history, more near work, and less time outdoors.

 Children who do more near work have a higher risk of developing myopia, while more outdoor time appears protective.

Why Is Myopia Control in Children Important?

When myopia keeps increasing, the concern is not only thicker glasses later. High myopia raises the risk of retinal detachment, glaucoma, early cataract, staphyloma, myopic macular degeneration, and other sight-threatening problems later in life. 

One review cited by NEI notes that retinal detachment risk is about five to six times higher in people with high myopia. (National Eye Institute) That is why doctors now talk about slowing the speed of progression, not just updating spectacles every year. 

In this blog, the two main clinical options are atropine eye drops for myopia and ortho-k lenses for children, because these are among the better-studied treatments used to slow eye growth.

What Is Atropine Eye Drops for Myopia?

Atropine therapy means using very low-dose atropine eye drops, once at night, to slow myopia progression. 

World Society of Paediatric Ophthalmology and Strabismus explains that atropine blocks muscarinic receptors, and while the exact mechanism is still not fully settled, the most likely explanation is that it affects retinal and scleral signaling involved in eye growth rather than simply relaxing focusing effort. (WSPOS)

The most discussed strengths today are 0.01%, 0.025%, and 0.05%. Over the last few years, 0.05% has looked strongest overall in the major LAMP data, and NEI’s 2024 expert summary described 0.05% as the optimal low concentration over five years, although long-term safety and response by ethnicity are still being studied. (National Eye Institute) 

In practice, atropine is considered in school-age children with clear progression, and trial data include children as young as 4 years old. A recent review noted that current treatment modalities are used from about 4–6 years up to 12–16 years, depending on the child’s refractive status, rate of change, and maturity for follow-up. (National Library of Medicine)

The treatment course is not a short one. Many children stay on atropine for at least 2 years, and some need longer treatment or restart treatment if progression speeds up again after stopping. The five-year LAMP follow-up found that many children needed retreatment after cessation, especially younger ones. (Science Direct)

Benefits of Atropine Eye Drops for Myopia Control

Before choosing treatment, it helps to see what atropine does well in daily life.

Side Effects and Risks of Atropine Therapy

Parents frequently search for atropine drops myopia side effects first, and that is a sensible question to ask.

• Light sensitivity and larger pupils can happen because atropine widens the pupil. This is more noticeable with stronger concentrations and is one reason many doctors prefer low-dose treatment.
• Blurred near vision can happen, especially with higher doses. In the 3-year MOSAIC results, about 20% of children starting 0.05% had transient near blur or photophobia, but there was no treatment discontinuation for this reason. (JAMA Network)
• Mild allergy or irritation can occur. Older atropine studies reported allergic reactions and glare more with stronger concentrations.
• Rebound after stopping is real. Faster progression after stopping atropine is well documented, and younger age, shorter treatment duration, and higher baseline myopia are linked with stronger rebound.
• Serious long-term harm has not been a major signal in trials, but that does not mean self-use is a good idea. No long-term increase in cataract or intraocular pressure in the available data, yet regular supervision still matters.

What Is Orthokeratology for Myopia?

Orthokeratology for myopia, shortened to Ortho-K, uses specially designed rigid contact lenses worn overnight. These lenses temporarily reshape the cornea, so the child can see clearly during the day without glasses or regular daytime contact lenses. 

It is a reverse-geometry lens system that also changes the way light falls on the peripheral retina, which is believed to help slow eye growth. 

In simple words, the lens does two jobs at once. It gives daytime vision correction and also slow myopia progression by creating peripheral myopic defocus, which sends a “slow down” signal to eye growth.

For children, Ortho-K is considered when the child and family can manage strict lens hygiene and follow-up. It is commonly used in school-age children, and has a stronger effect in some younger groups, especially around ages 6 to 8. 

Unlike atropine, the daytime vision benefit can start within days, but maximum correction takes around two weeks or longer, and the myopia-control benefit is judged over months and years, not overnight. Systematic reviews and meta-analyses have concluded that Ortho-K reduces axial elongation compared with standard single-vision correction over about two years. (WSPOS)

Treatment is ongoing rather than fixed like a short course of medicine. The reshaping effect lasts only while the lenses are worn consistently, and rebound can occur after discontinuation or after switching away from the method. 

Benefits of Ortho-K Lenses for Children

For some families, ortho-k lenses for children feel attractive because the child does not need spectacles during the day.

Side Effects and Risks of Ortho-K

The biggest question parents ask is not whether Ortho-K works, but whether it is safe enough for a child.

• Eye infection is the main serious concern. AAO notes a real risk of microbial keratitis with Ortho-K, and IMI reports about 13 cases of microbial keratitis per 10,000 child wearers per year. (AAO) (IMI)
• Corneal staining, lens fit problems, and mild corneal events can happen if the lens fit is poor or the care routine slips.
• Strict cleaning and follow-up are non-negotiable. This is not a casual contact lens. The safety of Ortho-K depends heavily on proper wear, storage, hand hygiene, and follow-up visits.
• Stopping the lenses can allow the effect to wear off, and some rebound in progression occurs after discontinuation or switch to another correction method.

Atropine vs Ortho-K - Which Option Is Better for Your Child?

There is no one universal winner. The better option depends on the child’s age, power, progression speed, daily routine, hygiene, and how much the family can commit to follow-up.

Other Myopia Control Treatment Options Worth Knowing

Atropine and Ortho-K are not the only choices. There are other effective or promising options such as myopia-control spectacle lenses, multifocal soft contact lenses, and simple behavior changes like more outdoor time and fewer long uninterrupted near-work sessions.

A good example is the BLINK trial, where high-add multifocal soft contact lenses produced meaningful slowing of eye growth compared with single-vision lenses. (National Eye Institute)

Outdoor time is still one of the simplest additions to any plan. The evidence for outdoor time is robust and that about 2 hours of daylight exposure appears helpful for both onset and progression, even though it is not a replacement for treatment in a fast progressor.

When Should You Start Myopia Control Treatment?

The ideal window is early, not late. Myopia starts between ages 6 and 14, and progression is faster in younger children, in those with higher starting myopia, and in children already progressing by more than 0.50 D per year.

So, in practical terms, treatment is considered as soon as a child is clearly myopic and showing ongoing progression, especially in the primary-school years, and myopia treatments tend to work best at younger ages, when progression is active,

This does not mean every child needs medicine or Ortho-K the day glasses start. But it does mean that a child with young onset, rising power, strong family history, or fast yearly change should not be told to “just wait and see” without discussing treatment.

Conclusion

Myopia control in children is not about removing glasses forever. It focuses on slowing the progression of myopia, one of the most common eye problems in children, by reducing the speed at which the eye continues to grow longer.

Atropine eye drops for myopia are simpler to start, while orthokeratology offers freedom from glasses during the day but requires much stricter lens care. The best plan depends on the child’s individual needs, not on what sounds newest or strongest online.

The next step is a proper paediatric eye or myopia-control assessment, especially if the child is young and their eye power is changing quickly.